In a surprise announcement recently, Apple Inc. preceded the debut of its new line of connected watches by unveilingResearchKit, a medical research platform that has demonstrated its powerful potential with the first five applications. The open-source ResearchKit and evolving HealthKit promise new ways for apps and researchers to gather sensor and health data that will enable faster clinical insights at lower cost.
Digital health and mobile health platforms have been emerging for a number of years, primarily in consumer health, but few with clinical rigor or clearance from the U.S. Food and Drug Administration. As in other product categories, Apple has used thoughtful design and its market strength to create a powerful new platform that lowers the barriers to creating apps. ResearchKit promises to benefit researchers, physicians and patients across a spectrum of diseases, from rare diseases to widespread chronic diseases that make up the majority of healthcare costs.
Apple’s new platform will amplify a broad set of new opportunities we are calling “Digiceuticals” — where software, sensors and apps are standalone treatments for disease and integrated into comprehensive care plans alongside drugs and medical devices. Leading academic groups have already demonstrated that digital tools can improve the effectiveness of drugs and health behavior change. Health platform investments by Apple AAPL, Google GOOG and Samsung KRX are lowering the barriers for reaching the right patient, time and place with engaging messaging customized for each patient.
In the digital age, it’s critical for retailers to collect and manage customer data. This information is the key to providing personalization for any kind of shopping experience, as it allows retailers to understand customer preferences and analyze shopping histories.
Smartphone payment systems like Apple Pay are an important method of obtaining this data since they allow data collection across different retailers for the same individual. However, when the data is collected and controlled by a third party like Apple, it is risky for retailers. Read More »
I’d heard a lot about Silicon Valley, but had lived and worked in Europe and Asia until I came to MIT Sloan School of Management. Passionate about bringing new technologies to market, I wanted to do an MBA program in the U.S. because, more than anywhere else, this is where taking risk is valued as a driver of change. That seems to be especially true in Silicon Valley, and I was eager to see it for myself.
Organizing our Technology Club’s annual Tech Trek to Silicon Valley, I planned visits to a mixture of hardware and software companies. I also requested that we meet with people from different functions, including product management, which is an area many MIT Sloan students are interested in these days.
The media spotlight has recently been on Apple Inc. AAPL +0.52% for shifting profits overseas to avoid U.S. taxes. In its international tax strategy, though, Apple is no different from other American technology companies, which (like Apple) began moving manufacturing overseas starting in the early 1980s.
Initially, U.S. technology firms that went abroad during this period were drawn by the lower labor, sourcing, and procurement costs. They also found they could eliminate exchange-rate risk by producing and selling in the same currency.
But these companies soon discovered another important advantage of being global: favorable taxation.
George Westerman (MIT Center for Digital Business), interviewed by Michael Fitzgerald
October 29, 2012
Big traditional companies get overlooked when it comes to digital transformation. But companies across all industry sectors are remaking their operations, their customer interactions, and even their business models. George Westerman tells us how they’re doing it, whether they are technology champions or beginners.